Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiv Gandhi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Emerging Infectious Diseases|August 23, 2023
Lymphocytic Choriomeningitis Virus in Person Living with HIV, Connecticut, USA, 2021Jonathan Dyal, Shiv Gandhi, Caitlin M Cossaboom, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
<i>De novo</i> emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case reportShiv Gandhi, Jonathan Klein, Alexander Robertson, et al.
Nature Communications|March 18, 2022
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case reportShiv Gandhi, Jonathan Klein, Alexander J Robertson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Emerging Infectious Diseases|August 23, 2023
Lymphocytic Choriomeningitis Virus in Person Living with HIV, Connecticut, USA, 2021Jonathan Dyal, Shiv Gandhi, Caitlin M Cossaboom, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
<i>De novo</i> emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case reportShiv Gandhi, Jonathan Klein, Alexander Robertson, et al.
Nature Communications|March 18, 2022
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case reportShiv Gandhi, Jonathan Klein, Alexander J Robertson, et al.
Pageof 2